Bronchial Asthma, Chronic Obstructive Pulmonary Disease and NF-κB

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Medicinal Chemistry

• Publication date

  2009-02-28

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.2174/092986709787549280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases

  2008cited by this paper
• Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.

  2008cited by this paper
• Immunomodulators for allergic respiratory disorders.

  2008cited by this paper
• Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review

  2008cited by this paper
• Journal of Occupational Medicine and Toxicology a Prospective Study of Decline in Lung Function in Relation to Welding Emissions

  2008cited by this paper
• Repression of Inflammatory Gene Expression in Human Pulmonary Epithelial Cells by Small-Molecule IκB Kinase Inhibitors

  2007cited by this paper
• Oxidative stress in pathogenesis of chronic obstructive pulmonary disease

  2007cited by this paper
• A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

  2007cited by this paper
• Antileukotriene drugs: clinical application, effectiveness and safety.

  2007cited by this paper
• Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases

  2007cited by this paper
• Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice Guideline

  2007influential reference
• Treating COPD--the TORCH trial, P values, and the Dodo.

  2007cited by this paper
• Glycogen synthase kinase-3beta inhibition attenuates asthma in mice.

  2007cited by this paper
• T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease

  2007cited by this paper
• Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms

  2007cited by this paper
• Modulatory effects of N-acetyl-l-cysteine on human eosinophil apoptosis

  2007cited by this paper
• Aryl Hydrocarbon Receptor-Deficient Mice Develop Heightened Inflammatory Responses to Cigarette Smoke and Endotoxin Associated with Rapid Loss of the Nuclear Factor-κB Component RelB

  2007cited by this paper
• Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD

  2007cited by this paper
• How Viral Infections Cause Exacerbation of Airway Diseases

  2006cited by this paper
• Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking.

  2006cited by this paper
• Cytokines or their antagonists for the treatment of asthma.

  2006cited by this paper
• Transcription factors in airway diseases

  2006cited by this paper
• Inhaled hyaluronic acid against exercise-induced bronchoconstriction in asthma.

  2006cited by this paper
• Modulation of Airway Remodeling and Airway Inflammation by Peroxisome Proliferator-Activated Receptor γ in a Murine Model of Toluene Diisocyanate-Induced Asthma1

  2006cited by this paper
• Antioxidant therapies in COPD

  2006cited by this paper
• Nutrients, nuclear receptors, inflammation, immunity lipids, PPAR, and allergic asthma.

  2006cited by this paper
• Targeting airway inflammation: novel therapies for the treatment of asthma.

  2006cited by this paper
• The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease.

  2006cited by this paper
• Kinase inhibitors and airway inflammation.

  2006cited by this paper
• Statin use is associated with reduced mortality in COPD

  2006cited by this paper
• The proteasome: a novel target for anticancer therapy

  2006cited by this paper
• NFκB pathway: A good signaling paradigm and therapeutic target

  2006cited by this paper
• NF-κB: A Stress-Regulated Switch for Cell Survival

  2006cited by this paper
• Basic mechanisms of development of airway structural changes in asthma

  2006cited by this paper
• Oxidants and signaling by mitogen-activated protein kinases in lung epithelium.

  2006cited by this paper
• Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease.

  2006cited by this paper
• Corticosteroid effects on cell signalling

  2006cited by this paper
• Can NF-kappaB be a target for novel and efficient anti-cancer agents?

  2006cited by this paper
• Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.

  2006cited by this paper
• Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophages

  2006cited by this paper
• Peroxisome proliferator‐activated receptor‐γ agonists as potential anti‐inflammatory agents in asthma and chronic obstructive pulmonary disease

  2006cited by this paper
• An antioxidant modulates expression of receptor activator of NF-κB in asthma

  2006cited by this paper
• Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages.

  2006cited by this paper
• The effect of a single inhaled dose of a VLA‐4 antagonist on allergen‐induced airway responses and airway inflammation in patients with asthma

  2006cited by this paper
• Are there any realistic chances to develop new drugs for asthma?

  2006cited by this paper
• Cilomilast for COPD: Results of a 6-Month, Placebo-Controlled Study of a Potent, Selective Inhibitor of Phosphodiesterase 4

  2006cited by this paper
• Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.

  2006cited by this paper
• Positive benefits of theophylline in a randomized, double‐blind, parallel‐group, placebo‐controlled study of low‐dose, slow‐release theophylline in the treatment of COPD for 1 year

  2006cited by this paper
• Role of lung maintenance program in the heterogeneity of lung destruction in emphysema.

  2006cited by this paper
• Chronic obstructive pulmonary disease: effects beyond the lungs

  2006cited by this paper
• Vitamin E down‐modulates mitogen‐activated protein kinases, nuclear factor‐κB and inflammatory responses in lung epithelial cells

  2006cited by this paper
• Inhibition of Tumor Necrosis Factor-α-Inducible Inflammatory Genes by Interferon-γ Is Associated with Altered Nuclear Factor-κB Transactivation and Enhanced Histone Deacetylase Activity

  2006cited by this paper
• Tackling COPD: a multicomponent disease driven by inflammation.

  2006cited by this paper
• Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.

  2006cited by this paper
• Agents against cytokine synthesis or receptors.

  2006cited by this paper
• Nedocromil sodium for chronic asthma in children.

  2006cited by this paper
• Immunomodulation

  2006cited by this paper
• Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells.

  2006cited by this paper
• Persistence of rhinovirus RNA after asthma exacerbation in children

  2005cited by this paper
• PPAR ligands: Potential therapies for metabolic syndrome

  2005cited by this paper
• Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.

  2005cited by this paper
• Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125.

  2005cited by this paper
• An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment.

  2005cited by this paper
• Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation.

  2005cited by this paper
• Antisense‐ and RNA interference‐based therapeutic strategies in allergy

  2005cited by this paper
• Allergen-induced peribronchial fibrosis and mucus production mediated by IκB kinase β-dependent genes in airway epithelium

  2005cited by this paper
• Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.

  2005cited by this paper
• First study of infliximab treatment in patients with chronic obstructive pulmonary disease

  2005cited by this paper
• Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases

  2005cited by this paper
• Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?

  2005cited by this paper
• Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma.

  2005cited by this paper
• PPARα downregulates airway inflammation induced by lipopolysaccharide in the mouse

  2005cited by this paper
• Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients.

  2005cited by this paper
• Inhaled corticosteroids: no association with pregnancy induced hypertension in asthmatics

  2005cited by this paper
• Inhibition of IKK down‐regulates antigen + IgE‐induced TNF production by mast cells: a role for the IKK‐IκB‐NF‐κB pathway in IgE‐dependent mast cell activation

  2005cited by this paper
• Lung myofibroblasts as targets of salmeterol and fluticasone propionate : inhibition of α-SMA and NF-κB

  2005cited by this paper
• Inflammatory cells and chronic obstructive pulmonary disease.

  2005cited by this paper
• Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

  2005cited by this paper
• Inhibitor of κB kinase is required to activate a subset of interferon γ-stimulated genes

  2004cited by this paper
• Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.

  2004cited by this paper
• Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.

  2004cited by this paper
• Mediators of Chronic Obstructive Pulmonary Disease

  2004cited by this paper
• Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma.

  2004cited by this paper
• Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice.

  2004cited by this paper
• Clinical interest of PPARs ligands.

  2004cited by this paper
• Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview

  2004cited by this paper
• PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats

  2004cited by this paper
• Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling

  2004cited by this paper
• NF-κB Activation in Airways Modulates Allergic Inflammation but Not Hyperresponsiveness1

  2004cited by this paper
• Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing☆

  2004cited by this paper
• Roles of peroxisome proliferator-activated receptor δ in skeletal muscle function and adaptation

  2004cited by this paper
• CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge

  2004cited by this paper
• NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight

  2004cited by this paper
• Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.

  2004cited by this paper
• Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice.

  2003cited by this paper
• A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts*

  2003cited by this paper
• Inhaled long acting beta agonists for stable chronic asthma.

  2003cited by this paper
• Systemic effects of chronic obstructive pulmonary disease

  2003cited by this paper
• Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.

  2003cited by this paper
• Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy 1

  2003cited by this paper

• Asian sand dust exacerbates airway inflammation in a mouse model of asthma

  2025cites this paper
• Exploring the Active Substances and Mechanism of Physalis Calyx seu Fructus Against Inflammation‐related Respiratory Diseases via Integrating Ultra‐Performance Liquid Chromatography‐Tandem Mass Spectrometry, Network Pharmacological Analysis, and Experimental Verification

  2025cites this paper
• Protective effect of Astragaloside II against lung injury in COPD based on mTORC1/GSK-3β signaling pathway.

  2024cites this paper
• Osthole attenuates asthma-induced airway epithelial cell apoptosis and inflammation by suppressing TSLP/NF-κB-mediated inhibition of Th2 differentiation

  2024cites this paper
• Anti-inflammatory and antioxidative effects of dexpanthenol on nicotine-induced lung injury in rats

  2023cites this paper
• S14G-Humanin ameliorates ovalbumin-induced airway inflammation in asthma mediated by inhibition of toll-like receptor 4 (TLR4) expression and the nuclear factor κ-B (NF-κB)/early growth response protein-1 (Egr-1) pathway

  2023cites this paper
• Transcriptomic Analysis Reveals a Link Between Hippo Signaling Pathway and Macrophages in Lungs of Mice with OVA-Induced Allergic Asthma

  2022cites this paper
• Bu-Shen-Fang-Chuan formula attenuates cigarette smoke-induced inflammation by modulating the PI3K/Akt-Nrf2 and NF-κB signalling pathways.

  2020cites this paper
• Immunological Basis of Oxidative Stress-Induced Lung Inflammation in Asthma and COPD

  2019cites this paper
• Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation

  2017cites this paper
• The effect of an IκB-kinase-β(IKKβ) inhibitor on tobacco smoke-induced pulmonary inflammation

  2016cites this paper
• Statins in Asthma: A Closer Look into the Pharmacological Mechanism of Action

  2016cites this paper
• Correlation between oxidative stress and the NF-κB signaling pathway in the pulmonary tissues of obese asthmatic mice

  2015cites this paper
• La BPCO : une maladie qui commence précocement

  2015cites this paper
• Antileukotriene Reverts the Early Effects of Inflammatory Response of Distal Parenchyma in Experimental Chronic Allergic Inflammation

  2013cites this paper
• 1,25-Dihydroxyvitamin D3 (1,25-(OH)2D3) Attenuates Airway Remodeling in a Murine Model of Chronic Asthma

  2013cites this paper
• 1,25‐Dihydroxyvitamin D3 Inhibits Nuclear Factor Kappa B Activation by Stabilizing Inhibitor IκBα via mRNA Stability and Reduced Phosphorylation in Passively Sensitized Human Airway Smooth Muscle Cells

  2013cites this paper
• Estudo da ativação eosinofílica e de matriz extracelular de tecido pulmonar periférico em cobaias com inflamação alérgica pulmonar: efeitos do tratamento com dexametasona e antagonista do receptor do cisteinil- leucotrieno D4

  2012cites this paper
• Novel role of NF-κB-p65 in antioxidant homeostasis in human kidney-2 cells.

  2012cites this paper
• Imaging Pulmonary NF-kappaB Activation and Therapeutic Effects of MLN120B and TDZD-8

  2011cites this paper
• Combined effects of TNF‐α, IL‐1β, and HIF‐1α on MMP‐2 production in ACL fibroblasts under mechanical stretch: An in vitro study

  2011cites this paper
• Mast cells and COPD.

  2011cites this paper
• TGF-β1 promoted MMP-2 mediated wound healing of anterior cruciate ligament fibroblasts through NF-κB

  2010cites this paper
• Lung Injury Biomarkers

  2010cites this paper